Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) will be reporting earnings this Monday after market hours. Here’s what ...

"This is a game changer for many who noticed a step change disease progression - some noticing improvement in function. Some ...

The FDA has deemed Biogen's tofersen reasonably likely to produce a clinical benefit for patients.

A week ago, Biogen Inc. ( NASDAQ:BIIB ) came out with a strong set of quarterly numbers that could potentially lead ...

Biogen beat Q2 estimates with cost control and new launches, but MS declines and pipeline risks cloud growth. Find out why ...